1,2-di(cyclic)substituted benzene compounds

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S317000, C544S392000, C544S395000, C546S221000, C546S225000, C546S226000, C546S228000

Reexamination Certificate

active

07410971

ABSTRACT:
A compound represented by the following general formula (1) or (100), a salt thereof or a hydrate of the foregoing has excellent cell adhesion inhibitory action or cell infiltration inhibitory action, and is useful as a therapeutic or prophylactic agent for various inflammatory diseases and autoimmune diseases associated with adhesion and infiltration of leukocytes, such as inflammatory bowel disease (particularly ulcerative colitis or Crohn's disease), irritable bowel syndrome, rheumatoid arthritis, psoriasis, multiple sclerosis, asthma and atopic dermatitis.wherein R10 represents optionally substituted cycloalkyl, etc., R20-23 represent hydrogen, alkyl, alkoxy, etc., R30-32 represent hydrogen, alkyl, oxo, etc., and R40 represents optionally substituted alkyl, etc.

REFERENCES:
patent: 5244901 (1993-09-01), George et al.
patent: 6929928 (2005-08-01), Cheng et al.
patent: 2002/0119973 (2002-08-01), Luly et al.
patent: 2002/0169155 (2002-11-01), Luly et al.
patent: 2003/0045516 (2003-03-01), Luly et al.
patent: 2004/0092507 (2004-05-01), Biggers et al.
patent: 2004/0224383 (2004-11-01), Cheng et al.
patent: 2004/0268439 (2004-12-01), Cheng et al.
patent: 2005/0014219 (2005-01-01), Cheng et al.
patent: 2005/0014795 (2005-01-01), Baroni et al.
patent: 2005/0261291 (2005-11-01), Kawahara et al.
patent: 2006/0276465 (2006-12-01), Kawahara et al.
patent: 2006/0281747 (2006-12-01), Kawahara et al.
patent: 5-186434 (1993-07-01), None
patent: 2003-506377 (2003-02-01), None
patent: 2003-192673 (2003-07-01), None
patent: 2004-523529 (2004-08-01), None
patent: 2005-505621 (2005-02-01), None
patent: WO-01/09138 (2001-02-01), None
patent: WO-02/18320 (2002-03-01), None
patent: WO-02/059108 (2002-08-01), None
patent: WO-03/033466 (2003-04-01), None
patent: WO-03/089410 (2003-10-01), None
patent: 2005/005382 (2005-01-01), None
patent: WO-2005/005382 (2005-01-01), None
patent: WO-2005-005382 (2005-01-01), None
patent: WO-2005/063705 (2005-07-01), None
patent: WO-2006/068058 (2006-06-01), None
patent: WO-2006/126635 (2006-11-01), None
Daniel K. Podolsky, N Engl J Med, vol. 347, No. 6, Aug. 8, 2002, pp. 417-429.
Subrata Ghosh et al., N Engl J Med, vol. 348;1 Jan. 2, 2003, pp. 24-32.
Takashi Shimoyama et al., Japanese Journal of Apheresis, vol. 18, No. 1 (1999), pp. 117-131.
G Barbara et al., Gut, 51 (Suppl 1), 2002, pp. i41-i44.
Susan E. Sweeney et al., The International Journal of Biochemistry & Cell Biology 36 (2004) pp. 372-378.
Mark Lebwohl, Lancet, vol. 361, Apr. 5, 2003, pp. 1197-1204.
Chris H Polman et al., The Lancet Neurology, vol. 2, Sep. 2003, pp. 563-566.
Mark Larché et al., J Allergy Clin Immunol, vol. 111, No. 3, 2003, pp. 450-463.
Michael P. Schön et al., The Journal of Investigative Dermatology, vol. 121, No. 5, Nov. 2003, pp. 951-962.
Marlon Cowart et al., J. Med. Chem. 2004, 47, pp. 3853-3864.
English language abstract of JP 5-186434 (Jul. 27, 1993).
English translation of IPER issued Aug. 22, 2006 in PCT/JP2004/019795.
Vippagunta et al., Advanced Drug Delivery Reviews, vol. 48, pp. 3-26, (2001).
“Merck Manual of Medical Information—Second Home Edition : Multiple Sclerosis” (online printout pp. 1-4). Last full review/revision Feb. 2003.
“Merck Manual of Medical Information—Second Home Edition: Atopic Dermatitis” (online printout pp. 1-8). Last full review/revision Dec. 2006.
“Merck Manual of Medical Information—Second Home Edition: Psoriasis” (online printout pp. 1-3). Last full review/revision Dec. 2006.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

1,2-di(cyclic)substituted benzene compounds does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 1,2-di(cyclic)substituted benzene compounds, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 1,2-di(cyclic)substituted benzene compounds will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4013187

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.